openPR Logo
Press release

Latest Report on Acute Pancreatitis Market : Global Key Players are - Abbott Laboratories, McNeil Consumer Healthcare, Sun BioPharma

02-08-2018 08:00 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Latest Report on Acute Pancreatitis Market : Global Key Players

Market Research Future published a Half Cooked research report on “Global Acute pancreatitis Market Research Report - Forecast to 2022” – Market Analysis, Scope, Stake, Progress, Trends and Forecast to 2022.
Acute pancreatitis (AP) is a systemic immunoinflammatory response to auto-digestion of the pancreas and peri-pancreatic organs. This condition is common and life threatening disease. With an annual incidence of 4.9–73 cases per 100000 people worldwide. The males are predominantly affected at young ages with a ratio of 2.5:1. The mortality rate for pancreatitis is between 1.5% and 4.2% according to large epidemiological studies, but is a frequent gastrointestinal disease with a morbidity rate of 30% in severe cases.

Get a sample report at https://www.marketresearchfuture.com/sample_request/1565 .

Regardless of the technological advances in critical care drugs in the course of recent years, the death rate has prevailed to approximately 10%. Acute pancreatitis is confirmed by medical history, physical examination, and typically a blood test (amylase or lipase) for digestive enzymes of the pancreas. The diagnosis of pancreatic is often difficult and treatments are therefore delayed because the organ is relatively inaccessible. The testing of acute pancreatits include techniques such as transabdominal ultrasound, endoscopic ultrasound (EUS), and magnetic resonance cholangiopancreatography (MRCP). Surgery has no role in mild acute pancreatitis or in severe pancreatitis with sterile necrosis. Surgical therapy in infected necrosis can be considered, based on the availability of other therapeutic options and the consistency of the necrotic material.
According to the 2013 American College of Gastroenterology (ACG) guidelines, antibiotics are usually not recommended in patients with acute pancreatitis, regardless of the type or disease severity. Infection must be suspected in patients who have signs of deterioration such as fever, increasing WBC count. Most infections in pancreatic necrosis are caused by single bacterial species from the gut. In patients with infected necrosis, antibiotics known to penetrate pancreatic necrosis, such as carbapenems, fluoroquinolones, and metronidazole, are recommended. Byetta (exanitide) is a drug from Eli Lily and Company that is FDA approved to treat acute pancreatitis.
The global acute pancreatitis market is expected to grow at a CAGR of 3.5% during forecasted period 2017-2023.
Abbott Laboratories (US), McNeil Consumer Healthcare (US), Sun BioPharma, Inc (US), Atox Bio Inc. (Israel), Calcimedica Inc. (US), D-Pharm Ltd (Israel), Dynavax Technologies Corporation (US), Glaxosmithkline Plc (UK) university’s and institutes are also included in the treatment of acute pancreatic like Radboud University, University Medicine Greifswald and others are some of the prominent players at the forefront of competition in the global acute pancreatitis market and are profiled in MRFR Analysis.

Access This report at https://www.marketresearchfuture.com/reports/acute-pancreatitis-market-1565 .

Geographically, the regional market is segmented into America, Europe, Asia Pacific, and the Middle East & Africa.
The North America dominated the global acute pancreatitis market with the U.S. holding the largest market share owing to numerous developments in the medical sector, and rising numbers of research institutes for better treatment of this diseases. The reported annual incidence of acute pancreatitis has ranged from 4.9 to 35 per 100,000 population. Acute pancreatitis is the leading gastrointestinal cause of hospitalization in the United States.
In Europe, the market for multiple sclerosis is expected to exhibit positive growth during the forecast period. The incidence of acute pancreatitis varies across Europe with gallstone dominantly spread across southern Europe and alcohol in Eastern Europe. In Western countries, the most common cause is alcohol, accounting for 65 percent of acute pancreatitis cases in the US, 20 percent of cases in Sweden, and 5 percent of those in the United Kingdom. In August, 2014, BSV BioScience GmbH, Germany received orphan designation for ulinastatin by the European Commission for the treatment of acute pancreatitis. This grant will help the company to acquire market share and enhance the customer base in Europe. The incidence of acute pancreatitis is increasing in many European and Scandinavian countries due to increased alcohol consumption and better diagnostic capability.

More Inquire at https://www.marketresearchfuture.com/enquiry/1565 .

Whereas Asia Pacific is expected to be a growing market for Acute Pancreatitis market and expected to grow at a rapid rate. The developing countries such as China and India are leading this market due to the fast growing healthcare sector and large unmet needs over the forecast period. The Middle East & African market especially, the African region is expected to witness a poor growth owing to the lack of knowledge in medical sector, and less development in medical facilities in Middle East & Africa will have limited growth in the market.

Continue…

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Latest Report on Acute Pancreatitis Market : Global Key Players are - Abbott Laboratories, McNeil Consumer Healthcare, Sun BioPharma here

News-ID: 936199 • Views:

More Releases from Market Research Future

Global Small Boat Industry Sees Growing Demand Amid Rising Recreational Boating and Coastal Activities
Global Small Boat Industry Sees Growing Demand Amid Rising Recreational Boating …
As per the latest analysis by Market Research Future, the Small Boats Market Size was estimated at 17.12 (USD Billion) in 2024. The Small Boats Market Industry is expected to grow from 17.88 (USD Billion) in 2025 to 26.41 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 4.43% during the forecast period (2025 - 2034). The global small boat industry is witnessing significant growth, driven
Automotive Trim Market Attaining USD 193.22 Billion till 2034 | Innovations Redefine Vehicle Aesthetics and Functionality
Automotive Trim Market Attaining USD 193.22 Billion till 2034 | Innovations Rede …
As per the latest analysis by Market Research Future, the Automotive Trim Market Size was estimated at 140.30 (USD Billion) in 2024. The Automotive Trim Market Industry is expected to grow from 144.87 (USD Billion) in 2025 to 193.22 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 3.25% during the forecast period (2025 - 2034). The automotive industry is witnessing a significant transformation in vehicle
Leading Automotive Technology Firms Expand Fuel Level Sensor Solutions for Next-Generation Vehicles | Robert Bosch Gmbh, Technoton
Leading Automotive Technology Firms Expand Fuel Level Sensor Solutions for Next- …
As per the latest analysis by Market Research Future, Automotive Fuel Level Sensor Market Size was valued at USD 5,788.04 million in 2024. The Automotive Fuel Level Sensor market industry is projected to grow from USD 6,008.32 million in 2025 to USD 9,201.90 million by 2035, exhibiting a compound annual growth rate (CAGR) of 4.35% during the forecast period (2024 - 2035). With the global automotive industry focused on precision,
Valet Parking Technology Gains Momentum as Urban Mobility and Smart Infrastructure Evolve | Market Growth with 15.62% CAGR
Valet Parking Technology Gains Momentum as Urban Mobility and Smart Infrastructu …
As per the latest analysis by Market Research Future, the Valet Parking Technology Market Size was estimated at 1.41 (USD Billion) in 2024. The Valet Parking Technology Market Industry is expected to grow from 1.63 (USD Billion) in 2025 to 6.01 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 15.62% during the forecast period (2025 - 2034). Valet parking technology is emerging as a transformative

All 5 Releases


More Releases for Acute

Acute Lymphoblastic Leukemia Therapeutics Market Size, Acute Lymphoblastic Leuke …
Acute Lymphoblastic Leukemia Therapeutics Market Dynamics are clarified by an in-depth review of facts on current and emerging trends. To understand a resource, the paper uses Porter's five forces to examine the importance of numerous qualities such as understanding of suppliers and customers, dangers provided by various agents, competitive strength, and promising new businesses. precious. Furthermore, the study covers numerous firms' Acute Lymphoblastic Leukemia Therapeutics research data, benefit, gross margin,
Acute Conjunctivitis Treatment Market: The Future Insights Of Global Acute Conju …
Acute Conjunctivitis Treatment Market Acute Conjunctivitis Treatment Market, or pink eye, is an irritation or inflammation of the conjunctiva that covers the white part of the eyeball. It can be caused by allergies or a bacterial or viral infection. Acute Conjunctivitis Treatment Market can be highly communicable and can be spread easily by the contact with secretions of eye from the infected person. Conjunctivitis often resolves on its own, but
Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H …
ReportsWorldwide has announced the addition of a new report title Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Renal Failure (ARF) (Acute Kidney Injury) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trials scenario. This report provides top line data relating to
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical T …
ReportsWorldwide has announced the addition of a new report title Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trials scenario. This report provides top line data relating to
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Tri …
ReportsWorldwide has announced the addition of a new report title Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017 to its growing collection of premium market research reports. GlobalData's clinical trial report, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) Global Clinical Trials Review, H1, 2017" provides an overview of Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) clinical trials scenario. This report provides top line data relating to
H2 2016 Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Therapeut …
Albany, New York, January 03, 2017: A recent forecast report focusing on the Acute Myelocytic Leukemia Market has been added to the wide portfolio of Market Research Hub (MRH). It is entitled as, “Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia) - Pipeline Review, H2 2016” which has been equipped by in-depth market examination with inputs from the industry experts. It covers the current market scenario and also its future growth